Get Aleteia delivered to your inbox. Subscribe here
Subscribe to Aleteia's free newsletter: Goodness. Beauty. Truth. No yelling.
Sign me up!

Not Prepared to Donate?

Here are 5 ways you can still help Aleteia:

  1. Pray for our team and the success of our mission
  2. Talk about Aleteia in your parish
  3. Share Aleteia content with friends and family
  4. Turn off your ad blockers when you visit
  5. Subscribe to our free newsletter and read us daily
Thank you!
Team Aleteia

Subscribe

Aleteia

One touch of this dime-sized disk can heal anything from flesh wounds to brain injuries

Share

Medical technology is bringing science-fiction to reality.

There is a new medical technology being developed and it’s the stuff science-fiction dreams are made of. USA Today reports that Tissue Nanotransfection (TNT) “injects genetic code into skin cells, turning those skin cells into other types of cells required for treating diseased conditions.”

The procedure is non-invasive and takes moments to complete. A medical professional places the “dime-sized” chip on the affected area and with one touch the injured flesh begins the healing process. Tissue Nanotransfection is easy to transport, Chandan Sen, director of the Center for Regenerative Medicine and Cell-Based Therapies, explains:

“This technology does not require a laboratory or hospital and can actually be executed in the field,” Sen said. “It’s less than 100 grams to carry and will have a long shelf life.”

Such a small medical tool would be easy to carry in an emergency medical kit and is expected to save the lives of many soldiers who are injured in combat. Because there is no need of transport to a hospital, soldiers could be healing moments after a wound is inflicted.

TNT is also not just for flesh wounds. Along with saving injured legs, TNT was able to restore brain function in a mouse which had suffered a stroke. The process used the mouse’s skin to grow new brain cells and showed that TNT is capable of working on any type of tissue.

While we are a long way off from seeing FDA approval for Tissue Nanotransfection, it is expected to begin human testing within the year.

Newsletter
Get Aleteia delivered to your inbox. Subscribe here.
Aleteia offers you this space to comment on articles. This space should always reflect Aleteia values.
[See Comment Policy]
Readers like you contribute to Aleteia's Mission.

Since our inception in 2012, Aleteia’s readership has grown rapidly worldwide. Our team is committed to a mission of providing articles that enrich, inspire and inform a Catholic life. That's why we want our articles to be freely accessible to everyone, but we need your help to do that. Quality journalism has a cost (more than selling ads on Aleteia can cover). That's why readers like you make a major difference by donating as little as $3 a month.